Founded in 2015, Outplay, Inc. is a science-driven, biotechnology company, based in North America. OPI’s mission is to discover and develop innovative, effective, and dependable methods of delivering peptides, biologics, and other molecules, transdermally. Leveraging our expertise in science, pharmaceuticals, and business development; our growing IP portfolio; and our expanding network of partners and licensees; OPI is well-positioned to become a global leader in the development and commercialization of transdermal delivery solutions.